|
NAA25 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.36539995871021E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.57410000484393E-08 |
| Normal-vs-Stage2 |
2.321900E-03 |
| Normal-vs-Stage3 |
3.58879999999839E-05 |
| Normal-vs-Stage4 |
1.53774999999134E-05 |
| Stage1-vs-Stage2 |
9.776600E-01 |
| Stage1-vs-Stage3 |
8.834600E-01 |
| Stage1-vs-Stage4 |
3.799400E-01 |
| Stage2-vs-Stage3 |
9.467000E-01 |
| Stage2-vs-Stage4 |
5.285600E-01 |
| Stage3-vs-Stage4 |
3.829000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.520500028806E-09 |
| Normal-vs-AfricanAmerican |
9.378700E-04 |
| Normal-vs-Asian |
2.005400E-04 |
| Caucasian-vs-AfricanAmerican |
3.355800E-01 |
| Caucasian-vs-Asian |
2.590000E-01 |
| AfricanAmerican-vs-Asian |
8.677700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.07239999792253E-08 |
| Normal-vs-Female |
7.10280001481323E-09 |
| Male-vs-Female |
2.962200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.247600E-02 |
| Normal-vs-Age(41-60Yrs) |
1.93860000274881E-08 |
| Normal-vs-Age(61-80Yrs) |
3.92669999849105E-08 |
| Normal-vs-Age(81-100Yrs) |
1.759390E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.812400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.053800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.628200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.564800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.682500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.870300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.237990E-03 |
| Normal-vs-Grade 2 |
3.25560001179781E-09 |
| Normal-vs-Grade 3 |
2.50339999996463E-06 |
| Normal-vs-Grade 4 |
3.978700E-04 |
| Grade 1-vs-Grade 2 |
9.734200E-01 |
| Grade 1-vs-Grade 3 |
3.932800E-01 |
| Grade 1-vs-Grade 4 |
7.511400E-01 |
| Grade 2-vs-Grade 3 |
4.618500E-02 |
| Grade 2-vs-Grade 4 |
5.359400E-01 |
| Grade 3-vs-Grade 4 |
5.083200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.70180000091946E-08 |
| Normal-vs-ccB subtype |
1.17459999948721E-07 |
| ccA subtype-vs-ccB subtype |
9.877600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.06659999721259E-08 |
| Normal-vs-N1 |
3.032100E-02 |
| N0-vs-N1 |
3.170600E-01 |
|
|
